MedPath

INBONE Total Ankle Arthroplasty(TAA)Using Calcaneal Stem Fixation

Terminated
Conditions
Arthrodesis
Complications; Arthroplasty, Mechanical
Degenerative Arthritis
Rheumatoid Arthritis
Interventions
Device: Radiographic evaluation of previously implanted patients
Registration Number
NCT01366989
Lead Sponsor
Stryker Trauma and Extremities
Brief Summary

The primary objective of this study is to evaluate the radiographic outcomes of Total Ankle Arthroplasty in patients having a calcaneal stem.

Detailed Description

The primary objective of this study is to determine the radiographic outcomes of patients who have received TAA with the calcaneal stem. Due to the fixation of the stem in the calcaneus, talar component position, osteolysis and bone quality are of interest to the FDA. Specifically, subsidence and/or migration of the talar component, osteolysis as a measure of wear, and bone quality of the talus, cuboid and navicular are to be evaluated in this study. Therefore, the radiographic outcomes of this study aim to assess these parameters

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
24
Inclusion Criteria

Patients who will be recruited for participation in this study received the TAA with calcaneal stem between December 6, 2005 and November 13, 2007 at approximately 28 sites.

Exclusion Criteria

Patients who will be recruited for participation in this study received the TAA with calcaneal stem between December 6, 2005 and November 13, 2007 at approximately 28 sites.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Total Ankle Arthroplasty with calcaneal stemRadiographic evaluation of previously implanted patientsPatients received the TAA with calcaneal stem between 12/6/05 \& 11/13/07 at approximately 28 sites.
Primary Outcome Measures
NameTimeMethod
Radiographic EvaluationPost operarative 1.2 -3.1 years

Bone quality of the talus, navicular, and cuboid will be assessed on both the lateral and mortise views of the latest follow-up radiographs

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Michael Bolognesi, MD

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath